+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glucagon Like Peptide 1 Agonist"

Prediabetes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Prediabetes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 130 Pages
  • Global
From
Diabetic Nephropathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Diabetic Nephropathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 134 Pages
  • Global
From
Anti-Diabetic Drug Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Anti-Diabetic Drug Market - Forecasts from 2025 to 2030

  • Report
  • January 2025
  • 140 Pages
  • Global
From
Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Type 2 Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Post-Bariatric Hypoglycemia - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Post-Bariatric Hypoglycemia - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Diabetes - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
Hypertriglyceridemia - Pipeline Insight, 2025 - Product Thumbnail Image

Hypertriglyceridemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Prader Willi Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Prader Willi Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hypoglycemia- Pipeline Insight, 2025 - Product Thumbnail Image

Hypoglycemia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Semaglutide Market Size, Emerging Insight, and Forecast to 2032 - Product Thumbnail Image

Semaglutide Market Size, Emerging Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
Type 2 Diabetes Pipeline Analysis Report - Product Thumbnail Image

Type 2 Diabetes Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
Liraglutide and Semaglutide Market by Type, by Route of Administration, by Application, by Distribution Channel, and by Region - Product Thumbnail Image

Liraglutide and Semaglutide Market by Type, by Route of Administration, by Application, by Distribution Channel, and by Region

  • Report
  • October 2024
  • 200 Pages
  • Global
From
Type 2 Diabetes Market 2025-2029 - Product Thumbnail Image

Type 2 Diabetes Market 2025-2029

  • Report
  • February 2025
  • 221 Pages
  • Global
From
Non-insulin Diabetes Therapeutics Market 2024-2028 - Product Thumbnail Image

Non-insulin Diabetes Therapeutics Market 2024-2028

  • Report
  • August 2024
  • 178 Pages
  • Global
From
Prediabetes Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Thumbnail Image

Prediabetes Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • April 2025
  • 184 Pages
  • Global
From
Diabetes Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Diabetes Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • February 2025
  • 184 Pages
  • Global
From
Metformin HCL Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2035F - Product Thumbnail Image

Metformin HCL Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2035F

  • Report
  • January 2025
  • 182 Pages
  • Global
From
Antidiabetics Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F - Product Thumbnail Image

Antidiabetics Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F

  • Report
  • June 2024
  • 183 Pages
  • Global
From
Semaglutide - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Thumbnail Image

Semaglutide - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • July 2024
  • 70 Pages
  • Global
From
Loading Indicator

The Glucagon Like Peptide 1 Agonist (GLP-1) market is a subset of the larger diabetes drugs market. GLP-1 agonists are a class of drugs used to treat type 2 diabetes, and are designed to mimic the effects of the hormone glucagon-like peptide-1 (GLP-1). GLP-1 agonists work by stimulating the release of insulin, reducing the amount of glucose in the blood, and slowing the rate of gastric emptying. GLP-1 agonists are typically administered via injection, and are used in combination with other diabetes medications. The GLP-1 agonist market is highly competitive, with a number of major pharmaceutical companies offering products. These include Novo Nordisk, Eli Lilly, Sanofi, AstraZeneca, and Boehringer Ingelheim. Show Less Read more